ClinicalTrials.gg
Drug

Ramipril clinical trials

Also written Altace and Tritace.

studies test it
108
open now
8
in phase 3
28
first study started
1995

Counted the way a researcher would: Ramipril with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Ramipril is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ramipril studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Jan 1991 · ALTACE · NDA 019901 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ramipril
80
Ramipril 10 mg capsule
3
Ramipril10 mg Capsules, single dose
3
ACE inhibitor
3
Altace@10 mg Capsules
2

Brand

Altace
14
Tritace
4
Delix®
2

Other names

Triatec®
1

In one entry with another drug

Given together, or one or the other

Telmisartan/Ramipril
2

Studies by the year they started

107 studies that test it; most in 2004 (12)

Studies that test Ramipril, by start year
YearStudies
19951
19981
20002
20013
20026
20033
200412
20057
200612
200711
20089
20094
20103
20115
20122
20131
20141
20153
20162
20184
20194
20202
20223
20242
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
17
Phase 2
15
Phase 3
28
Phase 4
42
No phase
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 42 · Other 66

Boehringer Ingelheim (9) · Sanofi (7) · Vanderbilt University (6) · Pfizer (4) · Teva Pharmaceuticals USA (3) · Gulhane School of Medicine (3) · Actavis Inc. (3) · Wake Forest University Health Sciences (2)

Often tested with

Tested in the same studies.

Telmisartan (11) · Candesartan (7) · Amlodipine (5) · Valsartan (5) · Irbesartan (4) · Hydrochlorothiazide (3) · Metoprolol (3) · Lisinopril (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Ramipril is the comparator. A study of two new drugs counts under both.

  • 1Sacubitril · John Paul II Hospital, Krakow · next primary completion Aug 2028
  • 1Valsartan · John Paul II Hospital, Krakow · next primary completion Aug 2028
Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Ramipril, phase 3 first.

Studies

Open first, then newest update. How each study uses Ramipril is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 108

See all 108 studies that test Ramipril →

Given beside what is tested · 7 — Ramipril is usual care or a partner of the new treatment
As the comparator · 23 — what is tested is compared with Ramipril

Showing 20 of 23.

Codes

What other systems call Ramipril · ClinicalTrials.gg INT008564

  • MeSH (NLM) D017257RamiprilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) L35JN3I7SJRAMIPRILConfirmed FDA, NLM, Wikidata
  • RxNorm 35296Confirmed FDA, Wikidata
  • Wikidata Q412666ramiprilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29411RamiprilOne source FDA
  • DrugBank DB00178One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.